权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Understanding Essential Protein Dynamics through the Anharmonic Properties of Thermally Excited Vibrations

通过热激发振动的非简谐特性了解基本蛋白质动力学

基本信息

批准号：
10566333
负责人：
Matthias Heyden
金额：
$ 22.42万
依托单位：
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
依托单位国家：
美国
项目类别：
财政年份：
2023
资助国家：
美国
起止时间：
2023-03-01 至 2027-02-28
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/10566333
关键词：
Address Algorithms Allosteric Site Binding Binding Sites Computer Hardware Computer software Computers Computing Methodologies Data Detection Development Diffusion Disease Drug Binding Site Drug Design Drug Targeting Drug toxicity Event Exhibits Extracellular Matrix Degradation FDA approved Face Family Freedom Frequencies Frustration Future Generations Goals Homologous Protein Individual Inflammatory Knowledge Laboratory Research Lead Link Matrix Metalloproteinase Inhibitor Matrix Metalloproteinases Methodology Methods Molecular Conformation Motion Neoplasm Metastasis Pathologic Pharmaceutical Preparations Potential Energy Property Protein Conformation Protein Dynamics Proteins Protocols documentation Sampling Side Structure Surface System Techniques Therapeutic Uses Universities Validation chronic inflammatory disease clinical application cluster computing computer framework computerized tools conformational conversion cost detection method drug candidate drug development drug discovery drug mechanism expectation high dimensionality inhibitor interest interoperability medication safety member millisecond molecular dynamics novel open source pharmacologic protein function rational design side effect simulation small molecule inhibitor software development supercomputer tumor vibration

项目摘要

The selectivity of orthosteric drugs is often limited by the structural similarity of their binding sites in homologous proteins, while allosteric binding sites are far less conserved. This allows allosteric drugs to bind a target protein with higher selectivity, which reduces the potential for side-effects and lowers drug toxicity. However, allosteric drug discoveries have been limited to serendipitous observations because rational allosteric drug design strategies face several inherent challenges. These challenges are directly related to current limits in the predictability of protein conformational fluctuations and collective dynamics that are central to the mechanisms of allosteric drugs. The objective of this project is the development of computational methods to facilitate the rational design of allosteric drugs via predictions of protein conformational fluctuations and collective dynamics from all-atom simulations. In principle, all-atom molecular dynamics simulations can directly explore protein conformational dynamics but require sampling on timescales of milliseconds to seconds for systems of pharmacological interest. Even with state-of-the-art enhanced sampling techniques, the associated computational costs and hardware requirements (special purpose computers, national supercomputers, large distributed computing networks) limit such applications to a small number of systems. This project aims to make the computational discovery of allosteric mechanisms in proteins more efficient and achievable with computer hardware available in most research laboratories and universities. To this end, the methods developed for this project maximize the information on inherent protein dynamics that can be extracted from molecular dynamics simulations. These methods will initially be applied to identify allosteric mechanisms in matrix metallo-proteinases (MMPs), which represent a family of structurally homologous proteins involved in the degradation of the extracellular matrix. Several members of the MMP family have been identified as drug targets in the context of chronic inflammatory disease and cancer metastasis. MMPs feature a highly conserved catalytic center, which results in a low selectivity of orthosteric small molecule inhibitors for individual MMPs and limits their therapeutic use. This project aims to identify allosteric mechanisms in MMPs that enable the targeted development of highly selective allosteric MMP inhibitors as potential drug candidates. The methods developed for this project are general and not specific to MMPs. They will thus be applicable for the identification of allosteric mechanisms in other drug target proteins and will be made available as open- source software.

正构药物的选择性往往受到其在同源物中结合位点结构相似性的限制